Insights

expanded capabilities Momentum is expanding its mass spectrometry offerings with CHIPP technology for scalable target profiling, presenting a chance to upsell enhanced target deconvolution services to biopharma clients seeking deeper profiling and throughput.

strategic acquisitions The acquisition of OmicScouts GmbH strengthens Momentum’s proteomics and MS capabilities and broadens geographic reach within Europe, enabling cross-sell opportunities to existing OmicScouts clients and a unified service ecosystem.

advisory strength Recent additions to the Scientific Advisory Board from OmicScouts co-founders and experts like Bernhard Kuster and Mathias Wilhelm can be leveraged to engage R&D-focused accounts seeking world-class MS/ proteomics guidance and collaborative projects.

proteomics focus Momentum’s expansion into proteomics services positions the company to target biotech firms needing comprehensive protein profiling, biomarker discovery, and proteome-wide analyses as part of drug discovery programs.

scale ready With a large Mass Spec lab housing 30+ instruments and a BL2 facility, Momentum can accommodate high-throughput projects for large partners, offering scalable capacity for peak demand periods and large compound libraries.

Similar companies to Momentum Biotechnologies

Momentum Biotechnologies Tech Stack

Momentum Biotechnologies uses 8 technology products and services including HubSpot Analytics, iCIMS, WordPress, and more. Explore Momentum Biotechnologies's tech stack below.

Media & News

Momentum Biotechnologies's Email Address Formats

Momentum Biotechnologies uses at least 3 email formats:
Momentum Biotechnologies Email FormatsExamplePercentage
FLast@momentum.bioJDoe@momentum.bio
100%
FLast@purehoneytech.comJDoe@purehoneytech.com
86%
Last@purehoneytech.comDoe@purehoneytech.com
14%

Frequently Asked Questions

What is Momentum Biotechnologies's official website and social media links?

Minus sign iconPlus sign icon
Momentum Biotechnologies's official website is momentum.bio and has social profiles on LinkedIn.

How much revenue does Momentum Biotechnologies generate?

Minus sign iconPlus sign icon
As of October 2026, Momentum Biotechnologies's annual revenue is estimated to be $10M - $25M.

What is Momentum Biotechnologies's SIC code and NAICS code?

Minus sign iconPlus sign icon
Momentum Biotechnologies's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Momentum Biotechnologies have currently?

Minus sign iconPlus sign icon
As of October 2026, Momentum Biotechnologies has approximately 24 employees across 2 continents, including North America and Europe. Key team members include Board Member: H. H. Explore Momentum Biotechnologies's employee directory with LeadIQ.

What industry does Momentum Biotechnologies belong to?

Minus sign iconPlus sign icon
Momentum Biotechnologies operates in the Biotechnology Research industry.

What technology does Momentum Biotechnologies use?

Minus sign iconPlus sign icon
Momentum Biotechnologies's tech stack includes HubSpot Analytics, iCIMS, WordPress, Cookiebot, Microsoft 365, Azure Active Directory, Vimeo and Piwik PRO Core.

What is Momentum Biotechnologies's email format?

Minus sign iconPlus sign icon
Momentum Biotechnologies's email format typically follows the pattern of FLast@momentum.bio. Find more Momentum Biotechnologies email formats with LeadIQ.

When was Momentum Biotechnologies founded?

Minus sign iconPlus sign icon
Momentum Biotechnologies was founded in 2014.
Momentum Biotechnologies logo

Momentum Biotechnologies

Biotechnology ResearchMassachusetts, United States11-50 Employees

Momentum Biotechnologies is a biotechnology research company based in Billerica, Massachusetts, that provides mass spectrometry–based drug discovery services to biopharma clients worldwide. As a drug discovery partner, it aims to accelerate programs by delivering rapid, high-quality data to identify and characterize leads across diverse target classes. The firm traces its roots to a team that developed the RapidFire high-throughput MS platform and has offered MS-enabled services since 2004, including work through PureHoney Technologies from 2015 to 2023. Its Billerica site houses a substantial mass spectrometry laboratory with more than 30 instruments and a fully equipped BL2 facility. In 2025 the company expanded through the acquisition of OmicScouts GmbH, a Munich-based proteomics CRO, which now operates as OmicScouts, a Momentum Biotechnologies Company. In May 2026 Momentum announced the launch of CHIPP technology to enable scalable and comprehensive target profiling.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $10M - $25M

    Momentum Biotechnologies's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.